by Cassie Sun | Nov 20, 2025 | Featured, Health & Science
WASHINGTON — Pharmaceutical executives and lawmakers warned that the United States’ reliance on foreign nations for key pharmaceutical components is disrupting the quality and access American patients have to generic medications at a Senate Special Committee on Aging...
by Luis Castaneda | Oct 5, 2023 | Featured, Health & Science
WASHINGTON – The Biden administration announced Tuesday that all 10 drug manufacturers it selected for the Medicare Drug Price Negotiations Program have agreed to participate. The drugs selected for the negotiations range from blood thinners like Eliquis and Xarelto;...
by Ester Wells | Feb 12, 2019 | Featured, Health & Science
WASHINGTON — House members on Tuesday sought solutions to rising drug prices from a panel of health leaders and emphasized their commitment to lowering out-of-pocket costs for consumers. “Americans are desperate for a solution to help them afford the quality,...
